Rapidly dissolving pharmaceutical composition
US9284341B2 · kind B2 · utility
0Cited by
0References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 11, 2013 |
| Grant date | Mar 15, 2016 |
| Priority date | — |
| Expiry date | Sep 11, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2072
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a pharmaceutical dosage form which may comprise carbamoyl glycinated chitosan, and particularly it relates to a pharmaceutical dosage form comprising the novel polymer in a lyophilized polymeric wafer form which shows rapid disintegration and dissolution characteristics in use.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.